Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
HIV Clinical Trials
|
April 19, 2011
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada
Nisha Andany, Janet M Raboud, Sharon Walmsley, et al.
Lancet (London, England)
|
December 19, 2006
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
Rodger D MacArthur, Richard M Novak, Grace Peng, et al.
HIV Clinical Trials
|
November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies
Michael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 18, 2018
Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical
Matthew Zahn, Amesh A Adalja, Paul G Auwaerter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy
Richard M Novak, Li Chen, Rodger D MacArthur, et al.
Critical Care Medicine
|
February 11, 2003
Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis
Timothy E Albertson, Edward A Panacek, Rodger D MacArthur, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
The anti-retroviral therapy emtricitabine affects skeletal muscle DNA methylation and transcriptome patterns in a male HIV mouse model
Alok Tripathi, Shabiha Sultana, Husam Bensreti, et al.
The Journal of Infectious Diseases
|
February 13, 2009
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes
Birgitte B Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek, et al.
Critical Care Medicine
|
January 11, 2005
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
Edward A Panacek, John C Marshall, Timothy E Albertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV
Edgar T Overton, Isabelle R Weir, Markella V Zanni, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
HIV Clinical Trials
|
April 19, 2011
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, Canada
Nisha Andany, Janet M Raboud, Sharon Walmsley, et al.
Lancet (London, England)
|
December 19, 2006
A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial
Rodger D MacArthur, Richard M Novak, Grace Peng, et al.
HIV Clinical Trials
|
November 29, 2007
The Incidence of HIV drug resistance and its impact on progression of HIV disease among antiretroviral-naïve participants started on three different antiretroviral therapy strategies
Michael J Kozal, Katherine Huppler Hullsiek, Rodger D Macarthur, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 18, 2018
Infectious Diseases Physicians: Improving and Protecting the Public's Health: Why Equitable Compensation Is Critical
Matthew Zahn, Amesh A Adalja, Paul G Auwaerter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 26, 2005
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy
Richard M Novak, Li Chen, Rodger D MacArthur, et al.
Critical Care Medicine
|
February 11, 2003
Multicenter evaluation of a human monoclonal antibody to Enterobacteriaceae common antigen in patients with Gram-negative sepsis
Timothy E Albertson, Edward A Panacek, Rodger D MacArthur, et al.
Biorxiv : the Preprint Server for Biology
|
November 26, 2025
The anti-retroviral therapy emtricitabine affects skeletal muscle DNA methylation and transcriptome patterns in a male HIV mouse model
Alok Tripathi, Shabiha Sultana, Husam Bensreti, et al.
The Journal of Infectious Diseases
|
February 13, 2009
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes
Birgitte B Simen, Jan Fredrik Simons, Katherine Huppler Hullsiek, et al.
Critical Care Medicine
|
January 11, 2005
Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels
Edward A Panacek, John C Marshall, Timothy E Albertson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIV
Edgar T Overton, Isabelle R Weir, Markella V Zanni, et al.
Page
of 5